EPSTEIN-BARR VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA IN HIV-INFECTED PATIENTS

被引:8
作者
HERNANDEZ, AM [1 ]
SHIBATA, D [1 ]
机构
[1] UNIV SO CALIF,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90033
关键词
AIDS; EBV; IMMUNOSUPPRESSION; LYMPHOMA;
D O I
10.3109/10428199509049760
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epstein-Barr virus (EBV) has been implicated in the pathogenesis of many lymphoproliferations arising in diverse settings, including HIV-infection. The precise roles of EBV may differ between these settings. For example, both the frequencies of EBV-association and the specific c-MYC translocations differ between sporadic and African Burkitt's lymphoma. Similarly, the frequencies of EBV-association in HIV-infected patients differs between anatomical sites, types of NHL, and geographic locations. HIV-related NHL have genetic alterations similar to NHL arising in the general population, and have less in common with the lymphoproliferations which arise in the setting of transplantation. However, the patterns of latent EBV transcription in systemic HIV-related NHL is unique among NHL, suggesting that EBV may contribute differently to their pathogenesis.
引用
收藏
页码:217 / 221
页数:5
相关论文
共 61 条
[51]  
Murray R.J., Wang D., Young L.S., Wang F., Rowe M., Kieff E., Rickinson A.B., Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP, J. Virol., 62, pp. 3747-3755, (1988)
[52]  
Murray R.J., Kurilla M.G., Brooks J.M., Thomas W.A., Rowe M., Kieff E., Rickinson A.B., Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies, J. Exp. Med., 176, pp. 157-168, (1992)
[53]  
Wang D., Liebowitz D., Kieff E., An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells, Cell, 43, pp. 831-840, (1985)
[54]  
Whittle H.C., Brown J., Marsh K., Greenwood B.M., Seidelin P., Tighe H., Wedderburn L., T-cell control of Epstein-Barr virus-infected B-cells is lost during P. falciparum malaria, Nature, 312, pp. 449-450, (1984)
[55]  
O'Conner G.T., Persistent immunological stimulation as a factor in oncogenesis with special reference to Burkitt's tumor, Am. J. Med., 48, pp. 279-285, (1970)
[56]  
Goldschmidts W.L., Bhatia K., Johnson J.F., Akar N., Gutierrez M.I., Shibata D., Carolan M., Levine A., Magrath I.T., Epstein-Barr Virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas, Leukemia, 6, pp. 875-878, (1992)
[57]  
Young L.S., Yao Q.Y., Rooney C.M., Sculley T.B., Moss D.J., Rupiani H., Laux G., Bornkamm G.W., Rickinson A.B., New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas, J. Gen. Virol., 68, pp. 2853-2862, (1987)
[58]  
Pelicci P.-G., Knowles D.M., Arlin Z.A., Wieczorek R., Luciw P., Dina D., Basilico C., Dalla-Favera R., Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders, J. Exp. Med., 164, pp. 2049-2060, (1986)
[59]  
Arber D.A., Shibata D., Chen Y.Y., Weiss L.M., Characterization of the topography of Epstein-Barr virus infection in human immunodeficiency virus associated lymphoid tissues, Mod. Pathol., 5, pp. 559-566, (1992)
[60]  
Birx D.L., Redfield R.R., Tosato G., Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders, N. Engl. J. Med., 314, pp. 874-879, (1986)